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PENGESANAN SEROLOGI DAN MOLEKULAR TOKSOPLASMOSIS 
DALAM KALANGAN PENDERMA DARAH DAN PESAKIT HEMATO-
ONKOLOGI DI HOSPITAL UNIVERSITI SAINS MALAYSIA 
 
ABSTRAK 
Toksoplasmosis adalah disebabkan oleh Toxoplasma gondii dan penyakit ini 
telah diketengahkan sebagai satu kesihatan awam yang membimbangkan, kerana satu 
pertiga penduduk dunia telah dijangkiti Toxoplasma gondii. Transmisi daripada 
penderma darah kepada pesakit terimunokompromi sebagai penerima darah telah 
menjadi satu kebimbangan. Kajian keratan rentas ini bertujuan untuk menyiasat 
kelaziman toksoplasmosis dalam kalangan penderma darah dan pesakit hemato-
onkologi di Hospital USM. Sejumlah 56 penderma darah dan 56 pesakit hemato-
onkologi telah diperiksa dengan kaedah esai imunoserapan terangkai enzim bagi anti-
T. gondii -imunoglobulin G (IgG) dan antibodi imunoglobulin M (IgM). Sampel yang 
positif bagi T. gondii IgG dan IgM telah seterusnya diuji untuk keavidan IgG. Semua 
asid deoksiribonukleik (DNA) yang diekstrak daripada sampel darah dianalisis untuk 
kehadiran gen Toxoplasma B1 dan ITS-1 dengan kaedah tindakbalas rantai 
polimerase. Data sosio-demografi dan ciri-ciri tingkah laku penderma dan pesakit telah 
dianalisa dengan menggunakan analisa statistik. Daripada 56 penderma darah, 23 
(41.07%) penderma adalah IgG+/IgM-, dan 2 (3.57%) penderma adalah IgG+/IgM+. 
Seorang penderma mempunyai indeks keavidan tinggi yang menunjukkan jangkitan 
masa lalu lebih daripada 20 minggu, manakala seorang lagi mempunyai indeks 
keavidan rendah yang menunjukkan jangkitan baru dalam masa 20 minggu. Sementara 
itu, 28 (50%) pesakit hemato-onkologi adalah seropositif untuk antibodi T. gondii, di 
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mana 27 (48.21%) pesakit adalah IgG+/IgM- dan seorang pesakit (1.79%) adalah 
IgG+/IgM+ dengan indeks keavidan tinggi. Tiada sampel (penderma dan pesakit) yang 
telah diuji positif untuk kehadiran gen Toksoplasma B1 dan kawasan ITS-1. Analisis 
Pearson Chi Square dan Fisher Exact Test menunjukkan hanya status pekerjaan 
dikaitkan dengan kadar seropositif Toksoplasma untuk populasi penderma darah. 
Walau bagaimanapun, untuk pesakit hemato-onkologi tiada faktor sosiodemografi dan 
ciri-ciri tingkah laku menunjukkan persamaan yang signifikan dengan kadar 
seropositif toksoplasmosis. Kesimpulannya, penderma darah dalam kajian ini pernah 
terdedah kepada jangkitan toksoplasmosis tetapi parasit ini mungkin telah 
dimusnahkan oleh sistem imuniti atau berada di dalam tisu-tisu lain. Oleh itu, darah 
adalah selamat untuk didermakan. Manakala, pesakit hemato-onkologi juga telah 
terdedah kepada jangkitan toksoplamosis sebelum ini dan parasit mungkin berada di 
dalam tisu-tisu lain jika ianya tidak dimusnahkan oleh sistem imuniti pesakit. Pesakit 
menghadapi risiko besar untuk mengalami pengaktifan semula jangkitan 











SEROLOGIC AND MOLECULAR DETECTION OF TOXOPLASMOSIS 
AMONG BLOOD DONORS AND HAEMATO-ONCOLOGY PATIENTS IN 
HOSPITAL UNIVERSITI SAINS MALAYSIA 
 
ABSTRACT 
Toxoplasmosis caused by Toxoplasma gondii and it has been highlighted as a 
public health concern, as one-third of the world population has been infected. Its 
transmission from blood donors to receiving immunocompromised patients has 
become a concern. This cross-sectional study aimed to investigate the prevalence of 
toxoplasmosis among blood donors and haemato-oncology patients in Hospital 
Universiti Sains Malaysia. A total of 56 blood donors and 56 haemato-oncology 
patients were screened by an enzyme-linked immunosorbent assay (ELISA) for anti-
T. gondii immunoglobulin G (IgG) and Immunoglobulin M (IgM) antibodies. Samples 
that were positive for T. gondii IgG and IgM were further tested for IgG avidity using 
ELISA. All extracted deoxyribonucleic acids (DNAs) from whole blood samples were 
analyzed for the presence of the Toxoplasma B1 gene and the ITS-1 region by PCR. 
The socio-demographic data and behavioral characteristics of donors and patients were 
analyzed using statistical analysis. Out of 56 blood donors, 23 (41.07%) donors were 
IgG+/IgM-, and 2 (3.57%) donors were IgG+/IgM+ with one of the donors having a 
high avidity index indicating as past infection for more than 20 weeks and the other 
with a low avidity index indicating as recent infection within 20 weeks. Meanwhile, 
28 (50%) of hemato-oncology patients were seropositive for T. gondii antibodies, 
where 27 (48.21%) patients were IgG+/IgM- and one patient (1.79%) was IgG+/IgM+ 
with high avidity index. None of the samples (donors and patients) tested positive for 
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the presence of the Toxoplasma B1 gene and ITS-1 region. Pearson Chi Square 
analysis and Fisher Exact Test showed that only employment status was significantly 
associated with Toxoplasma seropositivity rate for blood donors’ population. 
However, for haemato-oncology patients none of sociodemographic factors and 
behavioral characteristics showed a significant association with Toxoplasma 
seropositivity rate. As for the conclusion, blood donors have been exposed to T. gondii 
infection, but currently, the parasites have been destroyed by the immune system or 
could reside in other tissues. Thus, blood is considered safe for transfusion. 
Meanwhile, hemato-oncology patients might have been exposed to T. gondii infection, 
and the parasites may reside in other tissues if patients' immune systems did not destroy 





1.1       Introduction to Toxoplasma gondii 
Toxoplasmosis is one of the most common zoonotic diseases that has been highlighted 
in public health concern due to its high mortality rate or physical and/or psychological 
sequela in immunocompromised patients and congenitally infected neonates 
(Elsheikha et al., 2009; Tegegne et al., 2016).  It is a parasitic disease caused by 
Toxoplasma gondii (T. gondii), a coccidian parasite, and a spore-forming, single-celled 
obligate intracellular parasite belongs to an apicomplexan class. T. gondii is capable 
of infecting a wide range of warm-blooded animals, including humans. T. gondii was 
first discovered in North Africa by Nicolle and Manceaux in a hamster-like rodent 
(gondi). It was the widespread agent for zoonosis during 1908, which was named a 
year later (Paniker, 2007; Robert-Gangneux and Darde, 2012).  
Its medical importance remained uncertain until it was found and identified in 
tissues of newborn who were congenitally infected with severe symptoms such as 
hydrocephalus, retinochoroiditis, and encephalitis in 1939 (Innes, 2010; Robert-
Gangneux and Darde, 2012). In the mid-1970s, T. gondii were detected in 
immunocompromised patients, where the concept of reactivation of infection was 
extensively discovered by immunologists (Robert-Gangneux and Darde, 2012).  In the 
late 1960s, a cat was discovered as T. gondii definitive host, which harboured the 
parasitic sexual cycle and spreading oocyst of T. gondii through faeces (Paniker, 2007; 




1.1.1 Life Cycle of T. gondii 
Life cycle of T. gondii consists of two parts, the definitive host and intermediate host, 
and three infectious stages consisting of; sporulated oocyst which contains sporozoites, 
the rapidly dividing tachyzoites and tissue cyst containing slow-dividing bradyzoites 
(Dubey, 2016; Gunn and Pitt, 2012). Cats' family are their definitive hosts for its sexual 
reproduction phase, while human, mouse or other warm-blooded animals are their 
intermediate hosts for its asexual reproduction phase (Dubey, 1998; Retmanasari et 
al., 2017; Yohanes et al., 2014). Cats get infected upon ingestion of sporulated oocyst 
passed in another cats' faeces in the environment or consuming intermediate host 
harbouring tissue cysts or tachyzoites such as infected birds or mice (CDC - 
Toxoplasmosis, February 28, 2019). 
In the definitive host, the sexual reproduction phase starts when the parasites 
invade the intestinal cells of cats forming male and female gamete (Figure 1.1). 
Oocysts are formed after fertilization and released by the cells' disruption and shed off 
in cat faeces as unsporulated forms. After a few days in the environment, an 
unsporulated oocyst undergoes sporogony process, forming a sporulated oocyst that 
infects a wide range of intermediate hosts. The sporulated oocyst remains transmissible 
in the environment for months or even years (Gunn and Pitt, 2012). The contaminated 
environment may pollute other things such as crops or water, which located nearby, 
thus causing T. gondii to be transmissible to intermediate hosts (Lass et al., 2012; 
Sahimin et al., 2017). In humans, the parasites undergo an asexual reproductive cycle 
(Figure 1.1). T. gondii infects nucleated cells in humans and does not invade the red 
blood cells (Gunn and Pitt, 2012). Upon ingestion, oocyst releases sporozoites that 
penetrate the intestinal epithelium and differentiate into tachyzoites. These rapidly-
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dividing tachyzoites transform into tissue cyst containing bradyzoites, and localize in 
neural or muscle tissue.  
 
Figure 1.1: The life cycle of T. gondii in environment, definitive and intermediate  











1.1.2 Modes of T. gondii transmission 
Humans get infected with T. gondii through horizontal transmission including 
ingestion of contaminated food or drinks, consumption of raw or undercooked meat, 
exposure to contaminated soil, close contact with cats or vertical transmission from 
mother to foetus, organ transplantation and blood transfusion (Figure 1.2) (Abamecha 
and Awel, 2016; Davami et al., 2015; Dubey, 2004; Foroutan-Rad et al., 2016; 
Hussain et al., 2017; Jones et al., 2003; Sarkari et al., 2014). Consumption of 
contaminated foods or drinks that contain oocysts such as unwashed vegetables or 
fresh fruits from the garden where there are stray cats around could be the source of T. 
gondii transmission (Lass et al., 2012). This parasite remains dormant and resistant to 
freezing, high temperature, or any physical or chemical treatments in water (Robert-
Gangneux and Darde, 2012).  
Furthermore, humans can be infected with T. gondii by ingesting raw or 
undercooked meat containing tissue cyst. Toxoplasmosis is considered as a meat-borne 
disease where tissue cysts of T. gondii were found in pork (25%), mutton (10%), and 
less than 1% in beef and chicken (Ahmad et al., 2014; Brandon-Mong et al., 2015; 
Champoux et al., 2004; Hussain et al., 2017). Besides, a previous study reported that 
handling raw meat such as butchers or cooking the meat (tasting undercooked meat) 
can transmit T. gondii tissue cyst (Iddawela et al., 2017). T. gondii is also transmitted 
through their definitive host, a cat species. Infected cats shed a million T. gondii oocyst 
to the environment (Dabritz and Conrad, 2010; Mossalanejad et al., 2017; Paniker, 
2007). Kids who play with the cats and contaminated soil expose themselves to T. 




In addition, toxoplasmosis was reported to be transmitted through whole blood 
or white blood cell transfusion, organ transplant, and laboratory accidents even though 
it is rare (Ahmad et al., 2014; Alvarado-Esquivel et al., 2016; Elsheikha et al., 2009; 
Sarkari et al., 2014). Previous studies reported that T. gondii was transmitted through 
blood transfusion from seropositive donors to susceptible recipients due to its 
capability to survive in stored blood (Alvarado-Esquivel et al., 2016; Davami et al., 
2015; Elsheikha et al., 2009; Singh and Sehgal, 2010). Tachyzoites of T. gondii is one 
of the infectious stages that can invade all human cell types and survive for several 
weeks in the stored blood (Elhence et al., 2010; Robert-Gangneux and Darde, 2012). 
Thus, T. gondii tachyzoites in the blood can transmit the parasite to the recipients, 
especially those requiring multiple transfusions (Sarkari et al., 2014). Infected blood 
donor in acute phase infection is a significant contributor for this infection, especially 
in organ transplantation patient who need whole blood or white blood cell transfusion 
(Alvarado-Esquivel et al., 2016; Derouin and Pelloux, 2008; Sarkari et al., 2014; 
















1.1.3 Mechanisms of T. gondii in the human body  
Tachyzoites of T. gondii disseminate quickly (less than 40 s) from the initial site of 
infection in the intestine to distant tissues through the intestinal mucosa, lymphatic 
system and bloodstream during early phase of acute infection (Harker et al., 2015; 
Zenner et al., 1998). T. gondii invades those cells and continue to proliferate and 
eventually disrupt the cells (John and Petri, 2006). In healthy individuals with a normal 
immune system, most T. gondii are destroyed by competent killers of the parasite, 
macrophages (Ahmad et al., 2014).  
A healthy immune response is highly efficient at eliminating tachyzoites. 
However, some tachyzoites leak from this destruction, causing them to form a tissue 
cyst containing bradyzoites (Wohlfert et al., 2018). This persistent state, which is cyst-
forming bradyzoite, is more resilient and impervious (Betancourt et al., 2019; Blader 
and Saeij, 2009; Wohlfert et al., 2018).  This tissue cyst is commonly found in the 
central nervous system (CNS), eyes, skeletal or cardiac muscles of the host, causing 
inflammatory lesions (permanent damage) in immunocompromised patients or the 
foetus (Dunay et al., 2018). The multiplication process within this tissue cyst in a slow 
pace produces a cyst that contains thousands of bradyzoites (Ahmad et al., 2014). The 
tissue cyst remains dormant in healthy individuals, but it can be reactivated in 




1.2 Clinical symptoms of toxoplasmosis   
One-third of the world population was infected with toxoplasmosis and mostly were 
asymptomatic (Angal et al., 2016; Sahimin et al., 2017; Sarkari et al., 2014). Clinical 
symptoms of toxoplasmosis are less commonly reported even though T. gondii 
antibody is widely prevalent in humans throughout the world. Most infections in 
immunocompetent individuals were asymptomatic, or they present with mild 
symptoms such as fever, flu-like illness or cervical lymphadenopathy (Angal et al., 
2016; Sarkari et al., 2014). The parasites remain dormant for years in the body, but not 
in immunocompromised individuals and pregnant women, which can cause a life-
threatening disease (Davami et al., 2015; Sarkari et al., 2014). Severe complications 
associated with acute infections or reactivation of past infections were reported in 
immunocompromised patients such as encephalitis, chorioretinitis, and myocarditis 
(Arefkhah et al., 2019; Ben-Harari and Connolly, 2019; Ibrahim et al., 2017; Sahimin 
et al., 2017; Sarkari et al., 2014).  
1.2.1 Clinical symptoms of toxoplasmosis in immunocompromised group 
In immunocompromised patients, symptomatic toxoplasmosis was reported as 
acute, sub-acute, or chronic infections. The rapid proliferation of T. gondii occurs 
during infection resulting in various areas of tissue necrosis. The brain is the most 
common organ affected, which leads to severe complications because of the limited 
cell capacity to regenerate (Champoux et al., 2004). During acute infection, T. gondii 
may invade the mesenteric lymph nodes and liver parenchyma. The parasite can be 
found freely in the blood and peritoneal fluids during acute infection for a very short 
duration. A study on rodents found that T. gondii in the bloodstream took less than 40 
s to infect the small intestine, 18 hours to transform into tachyzoites, and reaching the 




associated with fever, headache, myalgia, anaemia, and lung problems are common 
symptoms during acute infection. With low immunity, the symptoms and signs may 
be prolonged, leading to sub-acute infection with severe manifestations. Tachyzoites 
continue to destroy the host cells and causing extensive lesions in the lung, liver, heart, 
brain, and eyes. The CNS has a lower immunity response than other tissues, making it 
prone to extensive damage from the tachyzoites invasion (Bogitsh et al., 2005). 
Chronic infection occurs when sufficient immunity is build-up to slow down 
the proliferation of tachyzoites. These cysts remain in the body without any apparent 
clinical effect. A cyst wall breaks and releases many bradyzoites, mostly killed by a 
host immune response, while some form a new cyst. When bradyzoites are killed, an 
inflammatory reaction occurs where the infected area, such as the brain, is gradually 
replaced with nodules of glial cells. The presence of many nodules will cause chronic 
encephalitis (Bogitsh et al., 2005). 
An example of a common manifestation of T. gondii infection among the 
immunocompromised group is Toxoplasmic encephalitis (TE). Patients with TE 
present with fever, headache, lethargy, incoordination due to muscle weakness, loss of 
memory, dementia, and focal/generalised seizures (Angal et al., 2016; Robert-
Gangneux and Darde, 2012; Sarkari et al., 2014). Other than TE, tachyzoites also 
infect retinal cells causing an extensive infection of a central, macular area, which 
leads to blindness and ocular toxoplasmosis. In severe cases of ocular toxoplasmosis, 






1.2.2 Clinical symptoms of congenital toxoplasmosis   
T. gondii can be transmitted through vertical transmission from mother to foetus, 
which is called congenital toxoplasmosis. During pregnancy, the innate immunity that 
protects the mother against T. gondii is suppressed, especially in the third trimester, 
thus making pregnant women more susceptible to infection (Abamecha and Awel, 
2016). The effects of T. gondii infection among pregnant women depend on the 
gestational age (Berredjem et al., 2017; Chemoh et al., 2019; Hafez Hassanain et al., 
2018). The severity of foetal disease varies between 0–9% during the first trimester, 
30% during the second trimester, and 35–59% during the third trimester (Malary et al., 
2018; Robert-Gangneux and Darde, 2012). When T. gondii infection occurs during the 
first and second trimesters, it is commonly accompanied by severe manifestations, 
such as low birth weight, hydrocephaly, intracranial calcifications, and 
retinochoroiditis, which are recognizable at birth (Sarvi et al., 2019). 
In contrast, infection during the third trimester will cause different 
manifestations such as intracranial calcifications, hearing impairments, developmental 
delays, and visual disorders later in life (Chemoh et al., 2019). Furthermore, congenital 
toxoplasmosis can result in abortion, foetal death, and abnormalities, such as blindness 
and severe cognitive impairment occurring after birth (Sarvi et al., 2019). Serious 
pathologic complications such as hydrocephaly, microcephaly, chorioretinitis, 
blindness, mental retardation, epilepsy, jaundice, abortion, and foetal death were 
reported in previous studies (Awoke et al., 2015; Elhence et al., 2010; Malary et al., 
2018; Svobodova and Literak, 1998). Another studies have further confirmed that 
screening and treatment for toxoplasmosis during pregnancy result in a decline of 
congenital transmission and clinical manifestation (Olariu et al., 2019). Researchers 




complications by 75% (Olariu et al., 2019). Early treatment during pregnancy has been 
shown to significantly decrease vertical transmission and improve clinical outcomes. 
 
1.3 Epidemiology of toxoplasmosis  
Approximately 10 to 70% of the worldwide human population has been exposed to T. 
gondii infection (Sarvi et al., 2019). According to the World Health Organization 
(WHO), about one million of toxoplasmosis in Europe is caused by contaminated food 
(Torgerson and Mastroiacovo, 2013). Different seroprevalence rate has been reported 
which are related to some environmental factors such as climatic conditions, 
geographical status, disease control and treatment, regional and ethnic customs and 
human activities (Yan et al., 2016). Globally, low seroprevalence (10 to 30%) of 
toxoplasmosis has been reported in North America, South East Asia, Northern Europe, 
and Sahelian countries in Africa. While in countries of central and Southern Europe, a 
moderate seroprevalence (30 to 50%) of toxoplasmosis was reported, and high 
seroprevalence was highlighted in Latin America and tropical African countries 
(Robert-Gangneux and Darde, 2012).  
A high prevalence of toxoplasmosis was reported in tropical countries with a 
humid and warm climate, and conversely, the lower prevalence was found for arid or 
colder countries (Champoux et al., 2004; Robert-Gangneux and Darde, 2012; 
Saadatnia and Golkar, 2012). Furthermore, toxoplasmosis is prevalent among kids 
who live under poor-hygiene conditions, which were probably linked to contaminated 
soil or waterborne disease (Abamecha and Awel, 2016; Robert-Gangneux and Darde, 
2012; Sahimin et al., 2017). This young age group are still not fully aware of good 




themselves to pathogenic organisms. Besides, in cases where both parents are working 
and not at home to supervise the children, it leads to a lack of parental guidance and 
some degree of carelessness, especially in personal hygiene and cleanliness (Sahimin 
et al., 2017). Thus, they were commonly exposed to infection and reinfection. 
1.3.1 Seroepidemiology of toxoplasmosis among blood donors 
Blood transfusion services collect blood from blood donors who are at low risk of any 
infection that is transmissible through transfusion and are unlikely to sacrifice their 
health through blood donation (WHO, 2013). Asymptomatic donors in acute infection 
with parasitemia can transmit the parasites to the recipients, especially in prevalent 
toxoplasmosis area (Robert-Gangneux and Darde, 2012). Blood grouping and 
compatibility testing, together with HIV, hepatitis B, hepatitis C, and syphilis 
screening, are among the quality assurance that was done to all donated blood. Since 
T. gondii screening before blood transfusion has not yet been practiced, 
immunocompromised patients are among susceptible groups that facing greater risk 
for acute and severe toxoplasmosis through blood transfusion (Foroutan and Majidiani, 
2018).  
In a global systematic and meta-analysis review, 33% of blood donors 
worldwide were seropositive for T. gondii (Foroutan and Majidiani, 2018; Wang et al., 
2018). While in Malaysia, there is only one prevalence study that was conducted 
among blood donors. This study showed a seroprevalence rate of toxoplasmosis among 
blood donors was 28.1% (Nissapatorn V et al., 2002). Malaysia has higher 
seroprevalence among blood donors than Turkey (19.5%) and Iran (19.3%). Other 
countries reported over 50.0% of toxoplasmosis among their blood donors, such as 
Northeast Brazil, north India, and Egypt (Alvarado-Esquivel et al., 2016; Foroutan-




characteristics that give potential exposure to the infection and different environments 
could be the reason for the varied seroprevalence rate among blood donors (Alvarado-
Esquivel et al., 2016). 
1.3.2 Seroepidemiology of toxoplasmosis among immunocompromised patients 
T. gondii has been suggested as an important opportunistic pathogen in 
immunocompromised patients. It causes life-threatening diseases in this group due to 
the risk of reactivation from the ruptured cyst (Ahmadpour et al., 2014; Wang et al., 
2017). A previous study has reported the epidemiological and its clinical aspects, 
especially among immunocompromised patients. For instance, more than 13 million 
of HIV patients worldwide were seropositive for T. gondii antibodies (Konstantinovic 
et al., 2019; Wang et al., 2017). The estimated prevalence ranges from 26.0% to 51.2% 
among cancer, HIV/AIDS, and transplant patients, respectively (Basavaraju, 2016; 
Wang et al., 2017). The prevalence rate was varied due to the different target groups, 
the type of assays used, and the year of the study (Basavaraju, 2016). The serological 
method gives a higher rate of seroprevalence than the molecular method; thus, 
combining both serological and molecular methods is recommended to accurately 
diagnose toxoplasmosis (Ghoneim et al., 2010). Furthermore, many types of assays 
used, such as enzyme-linked assays or haemagglutination assays with different 
sensitivities, specificities, and cut-off levels to define positive results, affect the 
prevalence rate (Foroutan-Rad et al., 2016).  So far, there is no study reported on the 
prevalence of toxoplasmosis among haemato-oncology patients. 
In Malaysia, the seroprevalence rate of toxoplasmosis among 
immunocompromised patients was between 41.9 to 51.2% (Daryani et al., 2011). In 




oncology patients reported that 41.9 % (54/129) patients were seropositive for 
toxoplasmosis. From this population, one patient (0.77%) was positive for T. gondii 
IgM antibody, three patients (2.32%) were positive for both IgM and IgG, and fifty 
patients (38.75%) were positive for T. gondii IgG antibody only (Nimir et al., 2010).  
The prevalence of toxoplasmosis among the immunocompromised group is different 
between geographical distributions. It was reported in Latin America, Europe, Asia, 
and Africa with 30.0% to 75.0%, USA with 3.0% to 42.0%, Malaysia with 41.9 % to 
51.2%, Thailand with 53.7 %, North India with 21.3%, China with 54.0%, Japan with 
5.4% and 50.0% in Ethiopia (Akanmu et al., 2010; Daryani et al., 2011; Uppal et al., 
2015; Wang et al., 2017).  
1.3.3 Seroepidemiology of toxoplasmosis among other groups 
In Malaysia, a few research were conducted to study the prevalence rate of this 
infection among different target groups such as pregnant women (Andiappan et al., 
2014), Orang Asli (Angal et al., 2016), people with close contact to animals (Brandon-
Mong et al., 2015), human immunodeficiency virus (HIV) patients (Ngui et al., 2011) 
and patients who specifically requested for toxoplasmosis screening (Mohamed and 
Hajissa, 2016). Based on these previous studies, 37.0 % of Orang Asli subgroups living 
in Peninsular Malaysia were found to be positive with toxoplasmosis (Ngui et al. 
(2011). There is another study focusing on pregnant women in West Malaysia, and 
39.73% of them were positive for anti-toxoplasma IgG. In comparison, another 2.74% 
were positive for both anti-toxoplasma IgG and anti-toxoplasma IgM (Andiappan et 
al., 2014).  A study among people having close contact with animals showed that 19.9 
% of 312 subjects were seropositive for T.gondii (Brandon-Mong et al. (2015). 
Another study was conducted in Hospital Universiti Sains Malaysia among patients 




samples were positive for IgM only and IgG only respectively (Mohamed and Hajissa, 
2016).  
 
1.4 Risk factors of toxoplasmosis 
Generally, risk factors are divided into two groups; sociodemographic factors and 
behavioural factors.  
1.4.1 Sociodemographic risk factors 
Sociodemographic factors are the combination of the population's social and 
demographic characteristics, such as age, gender, ethnicity, education level, migration 
background, marital status, economic or income status, and employment status. 
Studies have shown that age, gender, ethnicity, type of malignancies, residence area, 
and employment were significantly associated with Toxoplasma seropositivity 
(Brandon-Mong et al., 2015; Chemoh et al., 2019; Retmanasari et al., 2017; Yan et 
al., 2018).  
Older age groups have a low immune system that makes them more susceptible 
to infection (Alvarado-Esquivel et al., 2016; Sarkari et al., 2014; Zemene et al., 2012). 
Males are more prone to have T. gondii infection as they are actively involved in 
outdoor activities, sports, or even exposed to contaminated soil (Brandon-Mong et al., 
2015; Davami et al., 2015; Minbaeva et al., 2013; Retmanasari et al., 2017). In a multi-
racial country like Malaysia, Malay showed a higher prevalence of toxoplasmosis due 
to their close contact with cats and stray cats around their residential areas (Brandon-
Mong et al., 2015; Chemoh et al., 2019). Educational level and employment status are 
among risk factors that play roles in T. gondii infection (Siransy et al., 2016). Patients 




the risk of transmission. There were also reported cases of T. gondii transmission 
through organ transplant and blood transfusion, although rarely occurs (Alvarado-
Esquivel et al., 2016; Sarkari et al., 2014).  
1.4.2 Behavioural characteristics factors  
It has been discovered that consumption of raw or undercooked meat, eating unwashed 
vegetables or fruits, close contact with cats, poor hygiene and climatic factors were 
found to contribute in T. gondii transmission  (Alvarado-Esquivel et al., 2011; Avelar 
et al., 2018; Minbaeva et al., 2013; Tammam et al., 2013; Zemene et al., 2012). 
Undercooked meat might contain T. gondii tissue cyst that will be transmitted once 
ingested. Raw fruits or unwashed vegetables contaminated with oocyst might transmit 
the parasite to the host.  
Since the cat is a definitive host for T. gondii, close contact with cats might be 
a significant risk factor for its transmission (Dabritz and Conrad, 2010). The infection 
occurs through direct contact with cats’ faeces that are shedding oocyst after the first 
infection, and it needs at least a day for oocyst to sporulate and turn infectious (Avelar 
et al., 2018). In consequence, the presence of stray cats, or humans that have close 
contact with cats such as cleaning the cat litter box or having an indoor cat is more 
prone to T. gondii infection. In rural and remote areas, toxoplasmosis is considered a 
waterborne disease. T. gondii can be transmitted through contamination of water tanks 
with cat faeces or water supply that placed close by a farm where infected cats are 






1.5 Laboratory detection of toxoplasmosis 
There are two standard methods in detecting toxoplasmosis; indirect method (detect 
antibody) and direct method (detect the parasite). The indirect method is serological 
testing that measures specific anti-Toxoplasma immunoglobulin M (IgM) and 
immunoglobulin G (IgG) levels. The direct detection method uses tissue samples, 
cerebrospinal fluid (CSF), or other biopsy materials (Liu et al., 2015).  
1.5.1 Serological detection of toxoplasmosis 
T. gondii was first discovered in 1948 by the serological method (Sabin-Feldman dye 
test) before it was studied extensively (Paniker, 2007). Currently, ELISA is one of the 
most common serological tests used for toxoplasmosis detection (Abdoli et al., 2019; 
Chemoh et al., 2019). Generally, the serological test for toxoplasmosis is classified 
into two major groups. Those using disrupted parasites as an antigen source such as 
ELISA, complement fixation test, latex agglutination test (LAT) and indirect 
haemagglutination assay (IHA), and another group using complete organisms such as 
dye test, direct agglutination test (DAT) and a fluorescent antibody test (FAT) 
(Gillespie and Hawkey, 2002). Serological assay, especially ELISA, offers fast results, 
lower cost of preparation, high sensitivities and specificities, and it is well-accepted 
methods by clinicians (Thangarajah et al., 2019).  
 ELISA is a sensitive and specific analytic immunoassay used for the detection 
of the particular antibody. It is either quantitative or qualitative analysis of an analyte, 
usually an antigen, in a sample without the requirement of urbane or costly equipment 
(Konstantinou, 2017; Shah and Maghsoudlou, 2016). Qualitative determination is 
mainly detected in the presence or absence of a specific target, while quantitative 




(Konstantinou, 2017). Generally, the antigen is immobilized in a microplate well either 
directly or indirectly by a specific antibody known as a 'capture antibody.' A 'primary 
detection antibody' is added, forming an antigen-antibody complex. The primary 
detection antibody is either directly labelled with an enzyme (direct ELISA) or is itself 
attached to a secondary antibody known as a ‘secondary detection antibody’ (indirect 
ELISA). Between each step, the well is washed with a buffer solution. The addition of 
a substrate produces a colour signal indicating the presence of the antigen in the 
sample. The measurement of the optical density is proportional to the amount of 
antibodies in the sample.  
ELISA is widely used in clinical laboratories as a routine screening test due to 
its excellent diagnostic efficiency (100% specificity and 100% sensitivity) (Chemoh 
et al., 2019; Ghazy et al., 2007; Robert-Gangneux and Darde, 2012; Suresh et al., 
2012). For toxoplasmosis, ELISA is used as the routine screening test to detect 
Toxoplasma IgM, IgG, and IgG avidity in infected patients. It was initially described 
in 1976 (Gillespie and Hawkey, 2002; Rostami et al., 2018; Suresh et al., 2012). Since 
the IgM and IgG alone cannot be used as an indicator of recent infection, IgG avidity 
is used to determine a recent infection based on the development of immune response 
maturity. Technically, IgG avidity evaluates the binding avidity of IgG antibodies 
against T. gondii (Fonseca et al., 2017). Low avidity IgG antibodies indicate early 
infection (acute), and high avidity IgG antibodies indicate past infection (chronic) 
(Berredjem et al., 2017; Chemoh et al., 2019; Fonseca et al., 2017).  
During the first week of toxoplasmosis infection, IgA and IgM antibodies are 
produced and reach a plateau within 30 days (Figure 1.3) (Dard et al., 2016; Robert-




and become negative within less than seven months. Yet, it is still commonly 
detectable for about a year. Thus, IgM cannot be used as a marker to indicate recent 
infection unless the titer is very high. IgG antibodies can be detected from 1 to 3 weeks 
after the first escalation of IgM antibodies. After 2 to 3 months, these IgG antibodies 
reach plateau and decline but persist for a lifetime at residual titers (Robert-Gangneux 
and Darde, 2012).  
Many other serological tests have been used to detect toxoplasmosis, such as a 
dye test, which is a complement-mediated neutralizing antigen-antibody reaction 
(Gillespie and Hawkey, 2002). In addition, indirect fluorescent assay (IFA) is one of 
the simple serological tests that also measures Toxoplasma antibodies. This test 
requires using a fluorescence microscope (Liu et al., 2015; Saadatnia and Golkar, 
2012). Latex agglutination test (LAT) shows agglutination of the latex particle when 
there is the presence of T. gondii antibodies in the serum (Saadatnia and Golkar, 2012). 
Western blotting is also one of the conventional serological tests. Technically, sera are 
reacted with T. gondii antigen on a membrane transferred from polyacrylamide gel 
resulting in banding patterns that are matched with known molecular weight (Liu et 






Figure 1.3: Kinetics of the antibody (Ab) response of toxoplasmosis.  
                   The average kinetics of the different isotypes are represented, but they may 
vary among patients and different serological tests. Figure adapted from 




1.5.2 Molecular detection of toxoplasmosis 
Serological tests may fail to detect T. gondii infection in immunocompromised patients 
because of IgG or IgM antibody titer might not increase in these patients (Berredjem 
et al., 2017; Rahumatullah et al., 2012). To overcome the limitation of serological 
tests, different molecular techniques have been developed to detect the T. gondii DNA 
directly. The pcr underlies almost all of the modern molecular cloning. It is extensively 
used for diagnostic purposes to detect the presence of a specific DNA sequence of the 
organism in a biological fluid (Kadri, 2019). Using PCR, a defined target sequence 
within a DNA of high complexity and large size can be rapidly and selectively 
amplified in a quasi-exponential chain reaction that yields millions of copies. The 
result is easy to set up, inexpensive, and straightforward; the only requirement is some 
knowledge of the target's nucleotide sequences. In addition to its simplicity, PCR is 
robust, speedy, flexible, and sensitive (Green and Sambrook, 2020). The PCR is 
carried out in a reaction mixture which comprises the extracted DNA (template DNA), 
Taq polymerase, the primers, and the four Deoxyribonucleotide triphosphates (dNTPs) 
in excess in a buffer solution. The tubes containing the mixture reaction are subjected 
to repetitive temperature cycles using a thermal cycler machine involves three main 
steps; denaturation of DNA template, annealing of primers, and lastly, extension of 
DNA molecules. These steps are repeated for 30–40 cycles (Green and Sambrook, 
2020; Gupta, 2019; Kadri, 2019). 
Various types of PCR, including conventional PCR, multiplex PCR, and nested 
PCR, are widely available nowadays. Multiplex PCR is a conventional PCR that used 
more than one primer to detect multiple targets simultaneously. Performing three PCRs 




reactions. Additionally, this method may be adapted for the molecular diagnosis of any 
infectious disease, providing fast results with a small margin of error (Gonçalves-de-
Albuquerque et al., 2014). PCR assay has an advantage in the detection of recent and 
active infections as a reflection or marker for T.gondii parasitemia (Bakre, 2016). 
Nested PCR is a modified PCR that intended to reduce nonspecific binding of products 
that might be due to the amplification of unexpected primer-binding sites (Gupta, 
2019). Conventional PCR is a rapid, highly sensitive, and specific in detecting T. 
gondii. When combined with a serological test, it can distinguish chronic, acute, or 
reactivated toxoplasmosis (Castillo-Morales et al., 2012; Rahumatullah et al., 2012). 
PCR is useful for identifying or excluding acute toxoplasmosis or estimating the time 
of seroconversion (Berredjem et al., 2017).  
Burg and colleagues discovered PCR in detecting Toxoplasma infection in 
immunocompromised patients, congenital toxoplasmosis, and ocular toxoplasmosis 
(Montoya, 2002; Rahumatullah et al., 2012). PCR is an in vitro enzymatic 
amplification tool that amplifies specific T. gondii DNA from minute amounts of 
starting materials in a moment. 35-repeat BI gene of T. gondii genome was the first to 
be amplified by PCR and has been widely used for T. gondii detection (Robert-
Gangneux and Darde, 2012; Rostami et al., 2018). B1 gene is highly specific and well 
conserved for all T. gondii strains, including samples isolated from AIDS patients 
(Burg et al., 1989; Mesquita et al., 2010; Rahumatullah et al., 2012; Rostami et al., 
2018).  
Other than B1 gene, several multi-copy targeting genes including 529-bp 
repeated fragment, ITS-1 region, and P30 are among genes used for T. gondii detection 
in various biological samples (Bavand et al., 2019; Berredjem et al., 2017; Moshfe et 




a previous study showed that these target genes (B1 gene or the repeated region of T. 
gondii) present good sensitivity for clinical samples (Mesquita et al., 2010). Various 
clinical specimens have been used in PCR such as serum/plasma, amniotic fluid, 
placenta, brain tissue, aqueous humour and vitreous fluid for toxoplasmosis (Saki et 
al., 2017; Shafieenia et al., 2018). In addition, for immunocompromised patients, 
whole blood, urine, CSF, and other body fluids were used in detecting toxoplasmosis 
(Liu et al., 2015; Rostami et al., 2018).  
Nested PCR is a modified PCR which provides increased sensitivity and 
specificity of DNA amplification compared to conventional PCR. It is intended to 
reduce nonspecific binding in their products due to unexpected primer binding site 
amplification. In nested PCR, it involves two sets of primers where the first PCR 
product is used as a template for the second PCR (Liu et al., 2015).  It is rapid, 
sensitive, and effective molecular tools in acute toxoplasmosis detection of HIV 
patients (Alghamdi et al., 2016; Rostami et al., 2018).  Recent studies used nested PCR 
as an additional test to a serological method to detect and confirm the presence of T. 
gondii (Abdoli et al., 2019; Saki et al., 2017; Sarkari et al., 2014; Shafieenia et al., 
2018). 
Real-time PCR (RT-PCR) is another molecular method that can detect a low 
concentration of T. gondii DNA and amplify a million copies of target DNA in various 
body fluids (Liu et al., 2015; Steeples et al., 2015; Wells et al., 2015). Loop-mediated 
isothermal amplification (LAMP) is another type of molecular test which amplified 
the DNA under isothermal conditions with high efficiency (Liu et al., 2015). However, 
it is very sensitive to contamination; thus, extra precaution and good quality control 
are needed (Liu et al., 2015; Rostami et al., 2018). There are recent studies that used 




urine and also food and water sample (Fallahi et al., 2015; Fallahi et al., 2014; Gallas-
Lindemanna et al., 2013; Hu et al., 2012; Lalle et al., 2018). 
Nowadays, many ELISA and PCR kits are commercially available for 
toxoplasmosis, which offers various performances. For example, Platelia™ Toxo IgG, 
IgM and IgG Avidity (BioRad, USA), Elecsys® Toxo IgG and IgM (Roche, 
Germany), ELISA kit (ACON Biotech, Hangzhou China) and IgG and IgM µ-capture 
ELISA (Novalisa, Dietzenbach Germany), ELISA kit (Euroimmune, Germany). 
Among all these kits, Platelia™ Toxo IgG, IgM, and IgG Avidity (BioRad, USA) have 
100% sensitivity and 100% specificity for their packages. There are new rapid PCR 
kits that are available for T. gondii detection. For example, Toxoplasma gondii PCR 
Kit (MyBioSource.com, Canada), T. gondii Kit (VetMAX™, US), and Toxoplasma 
gondii kit (PCRmax, UK).  
 
1.6 Prevention and treatment of toxoplasmosis 
Since Toxoplasma infection can be transmitted through various routes, thus hygienic 
measures are crucial to avoid this infection. Besides, hygiene is the primary prevention 
of any parasitic infection. Washing hands regularly after having close contact with 
cats, gardening, or handling raw meat must be practiced. Furthermore, eating raw or 
undercooked meat should be avoided. Meat should be cooked appropriately at least 
56oC for 15 min or be frozen at -20oC so that T. gondii cyst can be eradicated (Ahmad 
et al., 2014; Robert-Gangneux and Darde, 2012). Individuals are encouraged to wash 
fruits and vegetables before eating them thoroughly. If the person owns a cat, the litter 
box should be handled carefully. Health education programs would help deliver useful 
information regarding possible infections, especially to children, 
immunocompromised patients, and pregnant mothers. Since T. gondii was reported to 
